Linked Life Data

19366850

Source:http://linkedlifedata.com/resource/pubmed/id/19366850

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2009-7-8
pubmed:abstractText
Parenteral iron administration has been associated with hypophosphatemia. Fibroblast growth factor 23 (FGF23) has a physiological role in phosphate homeostasis via suppression of 25-hydroxyvitamin D [25(OH)D] activation and promotion of phosphaturia. We recently reported a case of iron-induced hypophosphatemic osteomalacia associated with marked FGF23 elevation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1945-7197
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
94
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2332-7
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study.
pubmed:affiliation
Department of Endocrinology, Christchurch Hospital, Christchurch, New Zealand. Belinda.Robb@cdhb.govt.nz
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't